# ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Study · id `cardio:ct-nct01424722` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01424722](<https://clinicaltrials.gov/study/NCT01424722>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01424722

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 2258 participants.

## Technical summary

Registry record NCT01424722. Allocation not applicable; no masking; primary purpose diagnostic. Start 2011-08 (actual); primary completion 2017-06 (actual). Results posted on 2021-01-28.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 2258 participants (enrolled count; ClinicalTrials.gov record NCT01424722, source copy `cardio:ctgov-nct01424722-2021-01-28`, retrieved 2026-10-26)
- Started: 2011-08 (actual) (ClinicalTrials.gov record NCT01424722, source copy `cardio:ctgov-nct01424722-2021-01-28`, retrieved 2026-10-26)
- Primary completion: 2017-06 (actual) (ClinicalTrials.gov record NCT01424722, source copy `cardio:ctgov-nct01424722-2021-01-28`, retrieved 2026-10-26)
- Completion: 2017-06 (actual) (ClinicalTrials.gov record NCT01424722, source copy `cardio:ctgov-nct01424722-2021-01-28`, retrieved 2026-10-26)
- Results first posted: 2021-01-28 (ClinicalTrials.gov record NCT01424722, source copy `cardio:ctgov-nct01424722-2021-01-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01424722, source copy `cardio:ctgov-nct01424722-2021-01-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01424722-2021-01-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
- Acronym: AnalyzeST
- Condition: Coronary Artery Disease
- Intervention (Device): Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 68c4668873f6378bad6ece0837608fc3757d5e954b84159f1fe9d36b4f0a5dda
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
